OR17-4 Transcon Growth Hormone In The Treatment Of Pediatric Growth Hormone Deficiency: Results Of The Phase 3 Height Trial

TransCon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Phase 3 heiGHt Trial Background TransCon Growth Hormone is a sustained-release recombinant human growth hormone (hGH; somatropin) prodrug in development as a long-acting GH (LAGH) for children with growth...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Endocr Soc
Auteurs principaux: Thornton, Paul, Hofman, Paul, Maniatis, Aristides, Aghajanova, Elena, Chertok, Elena, Korpal-Szczyrska, Maria, Giorgadze, Elene, Kovalenko, Tatiana, Shu, Aimee, Karpf, David, Beckert, Michael, Leff, Jonathan
Format: Artigo
Langue:Inglês
Publié: Endocrine Society 2019
Sujets:
Pediatric Endocrinology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554858/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-OR17-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires